Frankenburg F R
Clozapine Clinic, McLean Hospital, Belmont, Massachusetts.
Psychiatr Clin North Am. 1994 Sep;17(3):531-40.
The story of the development of effective antipsychotic medications involves the collaboration of many people and organizations, ranging from Ayurvedic physicians to pharmaceutical companies, and the confluence of many quests, from that for improved synthetic dyes to that for an improved antimalarial agent. The disturbed behavior of patients and their evident anguish fueled the development of these drugs, which in turn has led to more research into the biochemistry of psychotic illnesses. Double-blind, placebo-controlled trials have established the true although partial utility of these new treatments. Most patients with schizophrenia--even those who have good responses to antipsychotic agents--continue to have some psychotic symptoms and to require a great deal of rehabilitation. It is hoped that physicians in the future will not find today's therapies as harmful as we find those of the past.
有效抗精神病药物的研发历程涉及众多人员和组织的协作,从阿育吠陀医师到制药公司,也涉及诸多探索的交汇,从对改进合成染料的探索到对改进抗疟药物的探索。患者的行为紊乱及其明显的痛苦推动了这些药物的研发,而这反过来又促使人们对精神疾病的生物化学进行更多研究。双盲、安慰剂对照试验已证实了这些新疗法虽不全面但真实的效用。大多数精神分裂症患者——即使是那些对抗精神病药物反应良好的患者——仍会有一些精神病症状,并且需要大量康复治疗。人们希望未来的医生不会觉得如今的疗法像我们认为过去的疗法那样有害。